涵盖了HER2的检测方法、时机、质控等关键方面，具体如下： 要点1：推荐检测方法 指南推荐采用免疫组化（IHC）和原位杂交法作为主要检测手段，以定量评估HER2蛋白的表达水平和基因扩增状态。当HER2 IHC评分为2+（不确定）时，建议结合原位杂交进行复核。

HER2-negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior... at 17:40 DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive ...

INSIHGT is an affordable, non-destructive and accessible 3D spatial biology method that maps diverse biomolecules deep within tissues, such as proteins and RNA, thus advancing the understanding of ...

As a HER2-targeted ADC, DV has been approved in China for patients with HER2-overexpressing (defined as immunohistochemistry [IHC] test results of 2+ or 3+) la/mUC previously treated with ...

Here we achieved a near-complete response in HR+, HER2amplified and overexpressing MBC twice through molecular tumor board (MTB) discussions: initially with trastuzumab deruxtecan (T-DXd) while HER2 ...

HER2-negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior ...

Japanese drugmaker Daiichi Sankyo (TYO: 4568) revealed on Friday that its Datroway (datopotamab deruxtecan; dato-dxd) has been approved in Japan for the treatment of adult patients with hormone ...

Tokyo: Daiichi Sankyo's DATROWAY (datopotamab deruxtecan) has been approved in Japan for the treatment of adult patients with hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH ...

ISLAMABAD: The Islamabad High Court (IHC) has directed Zong to return more than Rs2 billion collected incorrectly from its customers and abide by the decision of the telecom sector regulator in ...